Topic Hub

Insulin Glargine V2

2 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

2articles

17keywords mapped

2025-07-14latest review

Explore

Insulin Glargine V2 library

Showing 2 of 2 clinical reviews.

Questions2025-07-14

Lantus Autoimmune Disease Considerations: What Clinicians and Patients Need to Know

A clinician-level review of insulin glargine (Lantus) use in autoimmune disease: immunogenicity, anti-insulin antibodies, type 1 diabetes, thyroid and adrenal co-morbidities, and ORIGIN trial data.

Read clinical review

Safety2025-07-10

Lantus Cancer Risk Signal Review: What the Evidence Actually Shows

A clinician-level review of the insulin glargine (Lantus) cancer risk signal, covering the 2009 observational studies, the ORIGIN trial, mechanistic data on IGF-1R activation, and current prescribing guidance.

Read clinical review